Xeljanz Tofacitinib 5 mg tablets online at affordable price.

Xeljanz (tofacitinib citrate), an oral DMARD (disease-modifying anti-rheumatic drug), was approved by the U.S. Food and Drug Administration (FDA) on November 6, 2012. The drug is intended for the treatment of adults with moderately to severely active rheumatoid arthritis.

To know more about Arthritis Drugs Online, click here:- https://www.medslane.com/order/osteoporosis-arthritis-medicines/

Get a flash cashback in your wallet of 5% when your order Exceeds $500.